NCT01671982View on ClinicalTrials.gov

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2015

Conditions
HIV
Interventions
OTHER

Tenofovir Dose Adjustment

In subjects with a confirmed CLcr 30 to \<50 mL/min, switch tenofovir 300 mg every 48 hours, to 150 mg once daily for 2 weeks.

Trial Locations (5)

10330

HIV-NAT, Bangkok

20000

Chonburi Hospital, Chon Buri

20120

Sanpatong Hospital, Sanpatong

56000

Phayao Hospital, Phayao

Unknown

Nakornping Hospital, Chiang Mai

All Listed Sponsors
collaborator

The Government Pharmaceutical Organization

OTHER_GOV

collaborator

Chiang Mai University

OTHER

lead

Institut de Recherche pour le Developpement

OTHER_GOV

NCT01671982 - ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment | Biotech Hunter | Biotech Hunter